We are live on ! Find out more
KRTX

Karuna Therapeutics, Inc. Common Stock

Delisted

KRTX was delisted on the 15th of March, 2024.

2 hedge funds and large institutions have $270K invested in Karuna Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 325 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 3282 (-326)

100% less funds holding in top 10

Funds holding in top 10: 260 (-26)

100% less capital invested

Capital invested by funds: $12B → $270K (-$12B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 325

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-326
Holders Change %
-99.39%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
-26
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
1
Closed
325
Calls
$2K
Puts
Net Calls
+$2K
Net Calls Change
-$46.5M
Name Holding Trade Value Shares
Change
Change in
Stake
CS
101
Credit Suisse
Switzerland
-$12.4M -39,291 Closed
HNB
102
Huntington National Bank
Ohio
-$12.2M -38,411 Closed
Susquehanna International Group
103
Susquehanna International Group
Pennsylvania
-$12.1M -38,118 Closed
WCM Investment Management
104
WCM Investment Management
California
-$11.9M -37,686 Closed
Manulife (Manufacturers Life Insurance)
105
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$11.6M -36,755 Closed
BC
106
BIT Capital
Germany
-$11.2M -35,461 Closed
Man Group
107
Man Group
United Kingdom
-$11.1M -35,000 Closed
California State Teachers Retirement System (CalSTRS)
108
California State Teachers Retirement System (CalSTRS)
California
-$10.9M -34,434 Closed
HF
109
HRT Financial
New York
-$10.4M -32,868 Closed
Legal & General Group
110
Legal & General Group
United Kingdom
-$10.4M -32,839 Closed
Aberdeen Group
111
Aberdeen Group
United Kingdom
-$10.2M -32,217 Closed
CGPCS
112
Capital Group Private Client Services
California
-$10.1M -32,009 Closed
JP Morgan Chase
113
JP Morgan Chase
New York
-$9.67M -30,552 Closed
GPP
114
Great Point Partners
Connecticut
-$9.57M -30,250 Closed
Royal Bank of Canada
115
Royal Bank of Canada
Ontario, Canada
-$9.4M -29,693 Closed
GCIA
116
Gabelli & Co Investment Advisers
New York
-$9.38M -29,650 Closed
SC
117
Slotnik Capital
Texas
-$9.27M -29,300 Closed
Wells Fargo
118
Wells Fargo
California
-$8.93M -28,214 Closed
Schroder Investment Management Group
119
Schroder Investment Management Group
United Kingdom
-$8.5M -26,843 Closed
State of Wisconsin Investment Board
120
State of Wisconsin Investment Board
Wisconsin
-$8.34M -26,356 Closed
Envestnet Asset Management
121
Envestnet Asset Management
Illinois
-$7.74M -24,447 Closed
LP
122
LMR Partners
United Kingdom
-$7.56M -23,878 Closed
Allianz Asset Management
123
Allianz Asset Management
Germany
-$7.06M -22,300 Closed
CCM
124
Cinctive Capital Management
New York
-$7.05M -22,281 Closed
FAM
125
Fred Alger Management
New York
-$6.89M -21,776 Closed

KRTX Hedge Fund Activity: Q1 2024 in Review

2 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q1 2024, worth a combined $270K — down 100% from $12B a quarter earlier.

Sellers outnumbered buyers: 325 funds closed out of KRTX and 0 opened new positions — a net loss of 325 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Capital International Investors, exiting entirely with an estimated $1.34B sold.

  • 2 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q1 2024, down from 328 in Q4 2023.
  • Funds reported $270K of Karuna Therapeutics, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q1 2024 and 325 closed out, a net change of -325 holders.
  • The largest Karuna Therapeutics, Inc. Common Stock seller in Q1 2024 was Capital International Investors, an estimated $1.34B sold.

Based on aggregated 13F filings for Q1 2024.